The demand for innovative RNA synthesis technologies has surged in recent years, particularly due to the emergence of RNA-based therapeutic strategies such as vaccines. Circular RNAs (circRNAs) are attracting significant attention for their stability and potential therapeutic applications. Unlike linear RNAs, circRNAs are resistant to exonuclease degradation, displaying unique structural characteristics that enhance their stability. This attribute positions them as promising candidates for therapeutic development.
Advantages of Circular RNAs
The structural integrity of circRNAs allows for superior stability compared to traditional linear counterparts. Research indicates that these molecules can be significantly more stable—often several times—against degradation, making them ideal for therapeutic uses. Their potential extends beyond mere stability, as circRNAs.
IntegrateRNA has made substantial strides in developing optimized platforms for the in vitro synthesis of circular RNAs. With a focus on utilizing advanced circularization methods, the organization offers bespoke synthesis tailored for various research and therapeutic needs.
Our Synthesis Platforms
IntegrateRNA employs two pivotal systems for the synthesis of circular RNAs:
- T4 DNA/RNA Ligase Circularization System: This system ensures high efficiency and minimal by-products, facilitating seamless integration.
- CBITR Circularization System: Known for eliminating exogenous sequences while achieving a circularization efficiency exceeding ninety percent, this method is designed for both research-grade and pharmaceutical-grade production.
Key Features of Our Services
- No Residual Exogenous Sequences: Our circularization methods guarantee purity and specificity.
- High Circularization Efficiency: We achieve efficiency rates greater than ninety percent, ensuring a reliable product.
- Flexible RNA Length: We can produce circular RNAs ranging from twenty to three thousand nucleotides.
- Purity Standards: Both research-grade (eighty-five to ninety percent purity) and pharmaceutical-grade (over ninety-five percent purity) options are available.
Comprehensive Workflow
Our circular RNA synthesis follows a systematic workflow to ensure quality and reliability:
- Evaluation of your RNA sequence and design of a suitable circularization strategy.
- Preparation of template and performance of in vitro transcription.
- Purification of the linear RNA product.
- Execution of the RNA circularization process.
- Quality control steps to ensure integrity and purity, including RNase R digestion and analytical methods.
- Final purification and delivery of the freeze-dried product.
IntegrateRNA is dedicated to meeting the diverse needs of the research community, providing a robust synthesis service that actively supports the advancement of RNA science.
Why Choose IntegrateRNA?
Our synthesis services set a benchmark in the industry due to our commitment to quality, efficiency, and customer satisfaction. With an emphasis on reduced turnaround times and competitive pricing, we strive to be your partner in RNA research. If you have inquiries or require specific services, we encourage you to reach out.
